Dental-Pulp Stem Cells As a Therapeutic Strategy for Ischemic Stroke

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Apr 23

PMID 35453487

Authors

Chikako Nito

Satoshi Suda

Yuko Nitahara-Kasahara

Takashi Okada

Kazumi Kimura

Affiliations

Soon will be listed here.

Abstract

Regenerative medicine aims to restore human functions by regenerating organs and tissues using stem cells or living tissues for the treatment of organ and tissue defects or dysfunction. Clinical trials investigating the treatment of cerebral infarction using mesenchymal stem cells, a type of somatic stem cell therapy, are underway. The development and production of regenerative medicines using somatic stem cells is expected to contribute to the treatment of cerebral infarction, a central nervous system disease for which there is no effective treatment. Numerous experimental studies have shown that cellular therapy, including the use of human dental pulp stem cells, is an attractive strategy for patients with ischemic brain injury. This review describes the basic research, therapeutic mechanism, clinical trials, and future prospects for dental pulp stem cell therapy, which is being investigated in Japan in first-in-human clinical trials for the treatment of patients with acute cerebral ischemia.

Citing Articles

Dental pulp stem cells regenerate neural tissue in degenerative disorders and stroke rehabilitation: A scope systematic review.

Rahnama Sisakht A, Tavasouli Z, Negahi A, Hosseini S, Satarzadeh M Heliyon. 2024; 10(15):e35080.

PMID: 39166055 PMC: 11334686. DOI: 10.1016/j.heliyon.2024.e35080.

Priming and Combined Strategies for the Application of Mesenchymal Stem Cells in Ischemic Stroke: A Promising Approach.

Tian H, Tian F, Ma D, Xiao B, Ding Z, Zhai X Mol Neurobiol. 2024; 61(9):7127-7150.

PMID: 38366307 DOI: 10.1007/s12035-024-04012-y.

Adult Mesenchymal Stem Cells from Oral Cavity and Surrounding Areas: Types and Biomedical Applications.

Cabana-Munoz M, Pelaz Fernandez M, Parmigiani-Cabana J, Parmigiani-Izquierdo J, Merino J Pharmaceutics. 2023; 15(8).

PMID: 37631323 PMC: 10459416. DOI: 10.3390/pharmaceutics15082109.

The Importance of Stem Cells Isolated from Human Dental Pulp and Exfoliated Deciduous Teeth as Therapeutic Approach in Nervous System Pathologies.

Candelise N, Santilli F, Fabrizi J, Caissutti D, Spinello Z, Moliterni C Cells. 2023; 12(13).

PMID: 37443720 PMC: 10340170. DOI: 10.3390/cells12131686.

Mesenchymal Stem Cell Application and Its Therapeutic Mechanisms in Intracerebral Hemorrhage.

Yang G, Fan X, Mazhar M, Yang S, Xu H, Dechsupa N Front Cell Neurosci. 2022; 16:898497.

PMID: 35769327 PMC: 9234141. DOI: 10.3389/fncel.2022.898497.

References

Savitz S, Baron J, Fisher M . Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era. Stroke. 2019; 50(4):1026–1031. DOI: 10.1161/STROKEAHA.118.023927. View

Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N . Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab. 2012; 32(7):1317-31. PMC: 3390814. DOI: 10.1038/jcbfm.2011.187. View

Zhang Z, Zhang L, Jiang Q, Zhang R, Davies K, Powers C . VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000; 106(7):829-38. PMC: 517814. DOI: 10.1172/JCI9369. View

Egbuniwe O, Grant A, Renton T, Di Silvio L . Phenotype-independent effects of retroviral transduction in human dental pulp stem cells. Macromol Biosci. 2013; 13(7):851-9. DOI: 10.1002/mabi.201300020. View

Song M, Lee J, Bae J, Bu Y, Kim E . Human Dental Pulp Stem Cells Are More Effective Than Human Bone Marrow-Derived Mesenchymal Stem Cells in Cerebral Ischemic Injury. Cell Transplant. 2017; 26(6):1001-1016. PMC: 5657745. DOI: 10.3727/096368916X694391. View

Niizuma K, Borlongan C, Tominaga T . Application of Muse Cell Therapy to Stroke. Adv Exp Med Biol. 2018; 1103:167-186. DOI: 10.1007/978-4-431-56847-6_9. View

Zhang X, Zhou Y, Li H, Wang R, Yang D, Li B . Transplanted Dental Pulp Stem Cells Migrate to Injured Area and Express Neural Markers in a Rat Model of Cerebral Ischemia. Cell Physiol Biochem. 2018; 45(1):258-266. DOI: 10.1159/000486772. View

FRIEDENSTEIN A, PETRAKOVA K, Kurolesova A, Frolova G . Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6(2):230-47. View

Li S, Luo L, He Y, Li R, Xiang Y, Xing Z . Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 2021; 54(8):e13093. PMC: 8349657. DOI: 10.1111/cpr.13093. View

10.

Kawabori M, Shichinohe H, Kuroda S, Houkin K . Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. Int J Mol Sci. 2020; 21(19). PMC: 7582939. DOI: 10.3390/ijms21197380. View

11.

Lakhan R, Baylink D, Lau K, Tang X, Sheng M, Rundle C . Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice. Gene Ther. 2015; 22(9):721-8. DOI: 10.1038/gt.2015.40. View

12.

Sowa K, Nito C, Nakajima M, Suda S, Nishiyama Y, Sakamoto Y . Impact of Dental Pulp Stem Cells Overexpressing Hepatocyte Growth Factor after Cerebral Ischemia/Reperfusion in Rats. Mol Ther Methods Clin Dev. 2018; 10:281-290. PMC: 6108066. DOI: 10.1016/j.omtm.2018.07.009. View

13.

Zhang X, Zhou Y, Li H, Wang R, Yang D, Li B . Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia. Int J Mol Med. 2018; 41(6):3185-3194. PMC: 5881652. DOI: 10.3892/ijmm.2018.3517. View

14.

Suzuki T, Sato Y, Kushida Y, Tsuji M, Wakao S, Ueda K . Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy. J Cereb Blood Flow Metab. 2020; 41(7):1707-1720. PMC: 8217885. DOI: 10.1177/0271678X20972656. View

15.

Ozdemir A, Ozgul Ozdemir R, Kirmaz C, Eker Sariboyaci A, Unal Halbutogllari Z, Ozel C . The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol. 2016; 310:108-115. DOI: 10.1016/j.cellimm.2016.08.008. View

16.

Smith W, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind D . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008; 39(4):1205-12. DOI: 10.1161/STROKEAHA.107.497115. View

17.

Muroi K, Miyamura K, Okada M, Yamashita T, Murata M, Ishikawa T . Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Int J Hematol. 2015; 103(2):243-50. DOI: 10.1007/s12185-015-1915-9. View

18.

Fang C, Yang Y, Wang Q, Yao Y, Zhang X, He X . Intraventricular injection of human dental pulp stem cells improves hypoxic-ischemic brain damage in neonatal rats. PLoS One. 2013; 8(6):e66748. PMC: 3682969. DOI: 10.1371/journal.pone.0066748. View

19.

Savitz S, Yavagal D, Rappard G, Likosky W, Rutledge N, Graffagnino C . A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke). Circulation. 2018; 139(2):192-205. DOI: 10.1161/CIRCULATIONAHA.117.030659. View

20.

Leong W, Lewis M, Koblar S . Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade?. Stem Cells. 2013; 31(6):1040-3. DOI: 10.1002/stem.1348. View